Osteonic Co., Ltd. announced that it expects to receive KRW 5 billion in funding
March 25, 2019
Share
Osteonic Co., Ltd. (KOSDAQ:A226400) announced a private placement of 9th series unregistered coupon unguaranteed private convertible bonds for gross proceeds of KRW 5,000,000,000. The bonds carry a coupon of 0% and yield to maturity of 0%. The bonds will be convertible at a fixed conversion price of KRW 5,074 per share. The conversion period will be from March 28, 2020 to February 28, 2022. The payment date of the transaction is March 28, 2019. The transaction has been approved by the board of directors of the company. The transaction will involve participation from new investor Kimwoom Ion KOSDAQ Scale-up Venture Hedge Fund.
OSTEONIC Co., Ltd. is a Korea-based company mainly engaged in the manufacture and distribution of medical equipment. The Companyâs products mainly include cranio maxilla facial (CMF) systems and trauma systems. The products, including plates and screws, are used for fixing and healing broken bones in cranium, face, jaw, hands and feet. The Company also manufactures other medical equipment which is used in the process of fixing implants. The Company distributes its products within domestic market and to overseas markets.
OSTEONIC CO., LTD. 